Drug & intervention

insulin glulisine, human

RxCUI 400008

Clinical trials57
Recruiting0
Related conditions20
Synonyms2

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

40 shown
Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index MealNCT04019821 · 2020-01-01
COMPLETED
The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.NCT04124302 · 2019-10-01
COMPLETED
Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin TherapyNCT03359837 · 2018-01-20
COMPLETED
A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes MellitusNCT02910518 · 2017-02-17
COMPLETED
Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.NCT02685449 · 2016-02-01
UNKNOWN
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's DiseaseNCT02503501 · 2015-09-28
TERMINATED
Normal Versus Dual Wave Insulin Bolus for High-protein FoodNCT02276859 · 2014-10-01
COMPLETED
Effect of LIXIsenatide on the Renal SystemNCT02276196 · 2014-09-01
COMPLETED
Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational DiabetesNCT01662921 · 2013-04-01
COMPLETED
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)NCT01848990 · 2013-03-01
COMPLETED
Establishing Cardiovascular Biomarkers to Define Preferred Lantus® UseNCT01500850 · 2011-10-01
UNKNOWN
Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.NCT01436045 · 2011-09-01
COMPLETED
Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes MellitusNCT01678235 · 2011-09-01
COMPLETED
Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot StudyNCT01417897 · 2011-09-01
UNKNOWN
Apidra Children & Adolescents StudyNCT01202474 · 2011-05-01
COMPLETED
Diabetes in the Elderly: Prospective StudyNCT01131052 · 2011-03-01
COMPLETED
Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering DrugsNCT01203111 · 2010-12-01
COMPLETED
baSal BoluS Therapy in patIenTs With TypE 1 Diabetes MellitusNCT01204593 · 2010-11-01
COMPLETED
Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)NCT01212913 · 2010-08-01
COMPLETED
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes MellitusNCT01194245 · 2010-08-01
COMPLETED
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes MellitusNCT01194258 · 2010-08-01
COMPLETED
Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.NCT01122979 · 2010-07-01
COMPLETED
Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral NutritionNCT01081938 · 2010-02-01
TERMINATED
Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative StudyNCT01121835 · 2010-02-01
COMPLETED
Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use SettingNCT01079364 · 2010-01-01
TERMINATED
Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes PatientsNCT00965549 · 2009-07-01
COMPLETED
The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal ChildrenNCT00913497 · 2009-06-01
COMPLETED
Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes MellitusNCT00607087 · 2008-01-01
COMPLETED
Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General SurgeryNCT00596687 · 2007-12-01
COMPLETED
Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin AspartNCT01159353 · 2007-09-01
COMPLETED
Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 DiabetesNCT00824668 · 2007-08-01
COMPLETED
Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes MellitusNCT00526513 · 2007-07-01
COMPLETED
Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics StudyNCT00539448 · 2007-04-01
COMPLETED
Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes MellitusNCT00467376 · 2007-01-01
COMPLETED
Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 DiabetesNCT00562133 · 2006-12-01
COMPLETED
Insulin Glulisine in Type 2 Diabetic PatientsNCT00360698 · 2006-07-01
COMPLETED
Insulin Glargine "All to Target" TrialNCT00384085 · 2006-05-01
COMPLETED
Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory ControlNCT00283049 · 2006-02-01
TERMINATED
ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus.NCT00272064 · 2005-10-01
COMPLETED
APIDRA Registration StudyNCT00489190 · 2005-08-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.